During the past decade, Hospital Agamenon Magalhaes conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 6 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 4 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Agamenon Magalhaes" #1 sponsor was "Pfizer" with 4 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Brazilian Clinical Research Institute" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Agamenon Magalhaes" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Atea Pharmaceuticals, Inc." with 2 trials as a collaborator, "Ministry of Health, Brazil" with 2 trials as a collaborator, "Beneficência Portuguesa de São Paulo" with 1 trials as a collaborator and "Brazilian Research In Intensive Care Network" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Agamenon Magalhaes" are "COVID-19" (5 trials), "Cardiovascular Disease" (2 trials), "Heart Failure" (2 trials), "Myocardial Infarction" (2 trials) and "Acute Coronary Syndrome" (1 trials). Many other conditions were trialed in "Hospital Agamenon Magalhaes" in a lesser frequency.

Most popular intervention types in "Hospital Agamenon Magalhaes" are "Drug" (13 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Empagliflozin" (3 trials), "Clopidogrel" (2 trials), "PF-07321332" (2 trials) and "Ritonavir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Agamenon Magalhaes" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Agamenon Magalhaes". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Hospital Agamenon Magalhaes, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Agamenon Magalhaes, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".